What is ABBV's current stock price?

As of now, ABBV is trading at $229.32, with a daily change of +0.36%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ABBV Stock Analysis & IQ Rating | AbbVie

ABBV

AbbVie

$229.32

+$0.83 | +0.36%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$244.81

MKT CAP

$404.57B

52W Low

$164.39

VOL

$2.00M

P/E Ratio

173.02

AVG VOL

$5.47M

RSI

53.47

TREND

Uptrend

BQ Stock IQ

Login to see AbbVie (ABBV) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABBV Target Price

Login to display

Strengths

ABBV Rewards

Earnings are forecast to grow

ABBV Rewards

Trading below its fair value

ABBV Rewards

Outperform the market

ABBV Rewards

Investors confidence is positive

ABBV Price Performance

$226.08 (+1.43%)

$231.24 (-0.83%)

$198.64 (+15.45%)

$172.59 (+32.87%)

1year

6month

3month

1month

ABBV Risk Level

ABBV has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

ABBV Analysts Opinion

ABBV overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ABBV Analysts Opinion

ABBV Analysts opinion is positive but there was a setback from the past 3 months

ABBV Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

63%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

0%

80%

ABBV Street Sentiment

ABBV Street Sentiment is bullish and have positive views on the near-term outlook

ABBV Performance Sentiment

Sentiments overview associated with ABBV events and the stock performance.

63%

16%

Positive

Negative

12 out of 19
events present

3 out of 19
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$229.32

Resistance
Price

$211.96

Current Price Range

$230.85

Show methods +

Linked to ABBV

IQ

Close Price

Change

PFE

3.69

25.18

+1.12%

SNY

3.54

48.23

-0.47%

MRK

4.23

106.49

+1.13%

LLY

4.33

1078.75

+0.48%

TEVA

4.10

30.95

-0.85%

ABBV Latest Analysis +

Heres How AbbVies Neuroscience Portfolio Is Aiding Top-line Growth. ABBVs neuroscience franchise now drives more than 17% of revenues with strong Botox Vraylar and migraine drug sales fueling double-digit growth.

Fri Jan 2, 2026

$229.32 | +0.36%

Potential

BofA Cuts AbbVie (ABBV) Target While Maintaining Neutral View. AbbVie Inc. (NYSE:ABBV) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 15 BofA lowered the firms price target on AbbVie Inc. (NYSE:ABBV) to $233 from $248 and kept a Neutral rating. The firm said it sees a relatively clean setup for growth near the top end of the [….]

Tue Dec 30, 2025

$229.74 | -0.48%

Potential

Rating

3 No-Brainer Dividend Stocks to Buy Right Now. Key PointsAbbVies major drugs Skyrizi and Rinvoq are generating lots of sales.

Tue Dec 30, 2025

$229.74 | -0.48%

Potential

The Zacks Analyst Blog AbbVie The Coca-Cola Chevron ImmuCell and Precipio. AbbVie headlines todays top stock reports as Zacks highlights pharma recovery resilient beverages and Chevron???s evolving energy outlook.

Fri Dec 26, 2025

$229.98 | -0.07%

Potential

Top Stock Reports for AbbVie Coca-Cola & Chevron. ABBV KO and CVX headline Zacks top stock reports as analysts flag growth drivers strategic moves and key headwinds shaping 2025 outlooks.

Wed Dec 24, 2025

$229.89 | +0.48%

Potential

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. Key PointsAbbVie is a Dividend King that successfully navigated a challenging patent cliff.

Mon Dec 22, 2025

$227.91 | +0.47%

Activity

Potential

Microsoft Netflix Twilio And A Health Care Stock On CNBCs Final Trades. On CNBC'.s “.Halftime Report Final Trades”. Virtus Investment Partners’. Joseph M. Terranova named ) as his final trade.Lending support to his choice BTIG analyst Nick Altmann on Wednesday assumed Twilio with a Buy rating and announced a price target of $165. Don'.t forget to check out our premarket coverage hereRob Sechan CEO of NewEdge Wealth named ) as his final trade.Supporting his view Morgan Stan

Thu Dec 18, 2025

$222.82 | -0.68%

Rating

Heres How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today. AbbVie (NYSE:) has outperformed the market over the past 10 years by 1.89% on an annualized basis producing an average annual return of 14.56%. Currently AbbVie has a market capitalization of $396.56 billion.

Wed Dec 17, 2025

$224.31 | +0.31%

Activity

Analysts Split on AbbVie Inc. (ABBV) as BofA Cuts Target and HSBC Turns ish. We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now. TheFly reported on December 15 that Bank of America (BofA) lowered its price target for ABBV to $233 from $248 while maintaining a Neutral rating reflecting a modestly reduced valuation outlook even as the companys core business fundamentals remain solid. [….]

Wed Dec 17, 2025

$224.31 | +0.31%

Potential

Rating

Looking At AbbVies Recent Unusual Options Activity. Investors with a lot of money to spend have taken a ish stance on ).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals we don'.t know. But when something this big happens with ABBV it often means somebody knows something is about to happen.So how do we know what these investors just did?

Wed Dec 17, 2025

$224.31 | +0.31%

Momentum

FAQ About ABBV Stock Insights

What is ABBV current stock price?

What are ABBV stock strengths?

What is ABBV Risk Level?

What is ABBV market cap and volume?

What is ABBV current Stock IQ?

Should I buy ABBV stock right now?

Is ABBV a Strong Buy right now?

What does a 'Strong Buy' rating mean for ABBV?

What does a 'Strong Sell' rating mean for ABBV?

What factors influence ABBV's Stock IQ?

Explore our ABBV Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ABBV Stock Strategies
Effective Risk Management

FIND US ON

Receive our ABBV Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ABBV

AbbVie

Current Price

$229.32

+$0.83 | +0.36%

52W High

$244.81

MKT CAP

$404.57B

52W Low

$164.39

VOL

$2.00M

P/E Ratio

173.02

AVG VOL

$5.47M

RSI

53.47

TREND

Uptrend

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

ABBV Rewards

Earnings are forecast to grow

ABBV Rewards

Trading below its fair value

ABBV Rewards

Outperform the market

ABBV Rewards

Investors confidence is positive

Linked to ABBV

Symbol

IQ

Close

Change

PFE

3.69

25.18

+1.12%

SNY

3.54

48.23

-0.47%

MRK

4.23

106.49

+1.13%

LLY

4.33

1078.75

+0.48%

TEVA

4.10

30.95

-0.85%

ABBV Price Performance

$226.08 (+1.43%)

$231.24 (-0.83%)

$198.64 (+15.45%)

$172.59 (+32.87%)

1year

6month

3month

1month

ABBV Analysts Opinion

ABBV Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

ABBV Analysts Opinion

ABBV Analysts opinion is positive but there was a setback from the past 3 months

ABBV Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

63%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

0%

80%

ABBV Street Sentiment

ABBV Street Sentiment is bullish and have positive views on the near-term outlook

ABBV Risk Level

ABBV has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

ABBV Performance Sentiment

Sentiments overview associated with ABBV events and the stock performance.

63%

16%

Positive

Negative

12 out of 19
events present

3 out of 19
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$229.32

Resistance
Price

$211.96

Current Price Range

$230.85

Show methods +

ABBV Stock IQ

Login to unlock AbbVie (ABBV) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABBV Latest Analysis

Heres How AbbVies Neuroscience Portfolio Is Aiding Top-line Growth. ABBVs neuroscience franchise now drives more than 17% of revenues with strong Botox Vraylar and migraine drug sales fueling double-digit growth.

Fri Jan 2, 2026

$229.32 | +0.36%

Potential

BofA Cuts AbbVie (ABBV) Target While Maintaining Neutral View. AbbVie Inc. (NYSE:ABBV) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 15 BofA lowered the firms price target on AbbVie Inc. (NYSE:ABBV) to $233 from $248 and kept a Neutral rating. The firm said it sees a relatively clean setup for growth near the top end of the [….]

Tue Dec 30, 2025

$229.74 | -0.48%

Potential

Rating

3 No-Brainer Dividend Stocks to Buy Right Now. Key PointsAbbVies major drugs Skyrizi and Rinvoq are generating lots of sales.

Tue Dec 30, 2025

$229.74 | -0.48%

Potential

The Zacks Analyst Blog AbbVie The Coca-Cola Chevron ImmuCell and Precipio. AbbVie headlines todays top stock reports as Zacks highlights pharma recovery resilient beverages and Chevron???s evolving energy outlook.

Fri Dec 26, 2025

$229.98 | -0.07%

Potential

Top Stock Reports for AbbVie Coca-Cola & Chevron. ABBV KO and CVX headline Zacks top stock reports as analysts flag growth drivers strategic moves and key headwinds shaping 2025 outlooks.

Wed Dec 24, 2025

$229.89 | +0.48%

Potential

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. Key PointsAbbVie is a Dividend King that successfully navigated a challenging patent cliff.

Mon Dec 22, 2025

$227.91 | +0.47%

Activity

Potential

Microsoft Netflix Twilio And A Health Care Stock On CNBCs Final Trades. On CNBC'.s “.Halftime Report Final Trades”. Virtus Investment Partners’. Joseph M. Terranova named ) as his final trade.Lending support to his choice BTIG analyst Nick Altmann on Wednesday assumed Twilio with a Buy rating and announced a price target of $165. Don'.t forget to check out our premarket coverage hereRob Sechan CEO of NewEdge Wealth named ) as his final trade.Supporting his view Morgan Stan

Thu Dec 18, 2025

$222.82 | -0.68%

Rating

Heres How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today. AbbVie (NYSE:) has outperformed the market over the past 10 years by 1.89% on an annualized basis producing an average annual return of 14.56%. Currently AbbVie has a market capitalization of $396.56 billion.

Wed Dec 17, 2025

$224.31 | +0.31%

Activity

Analysts Split on AbbVie Inc. (ABBV) as BofA Cuts Target and HSBC Turns ish. We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now. TheFly reported on December 15 that Bank of America (BofA) lowered its price target for ABBV to $233 from $248 while maintaining a Neutral rating reflecting a modestly reduced valuation outlook even as the companys core business fundamentals remain solid. [….]

Wed Dec 17, 2025

$224.31 | +0.31%

Potential

Rating

Looking At AbbVies Recent Unusual Options Activity. Investors with a lot of money to spend have taken a ish stance on ).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals we don'.t know. But when something this big happens with ABBV it often means somebody knows something is about to happen.So how do we know what these investors just did?

Wed Dec 17, 2025

$224.31 | +0.31%

Momentum

Discover ABBV Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ABBV. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ABBV Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ABBV Stock trends

ABBV Stock performance

ABBV Stock analysis

ABBV investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABBV

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABBV

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

ABBV Stock Analysis & IQ Rating | AbbVie

BQ Stock IQ

ABBV Target Price

ABBV Risk Level

ABBV Analysts Opinion

ABBV Street Sentiment

ABBV Performance Sentiment

Technical Price Levels

Explore our ABBV Stock insights

Receive our ABBV Daily Alerts

ABBV Street Sentiment

ABBV Risk Level

Technical Price Levels

Discover ABBV Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ABBV. We're here to help you make informed investment decisions today.

Receive our ABBV Daily Alerts

ABBV Alerts